111 (YI) Cash & Equivalents Growth (1y) (2018 - 2025)
111 (YI) Cash & Equivalents Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -30.15% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 10.03% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 18.37% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 8.66% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | -99.89% |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 11.94% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 466.79% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -39.13% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 21.75% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -30.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.94% |
| Sep 30, 2025 | -7.86% |
| Jun 30, 2025 | 0.97% |
| Mar 31, 2025 | -8.77% |
| Dec 31, 2024 | -23.22% |
| Sep 30, 2024 | -23.42% |
| Jun 30, 2024 | -16.05% |
| Mar 31, 2024 | -6.72% |
| Dec 31, 2023 | -11.51% |
| Sep 30, 2023 | -1.60% |
| Jun 30, 2023 | -16.85% |
| Mar 31, 2023 | -23.76% |
| Dec 31, 2022 | -8.44% |
| Sep 30, 2022 | -1.41% |
| Jun 30, 2022 | -37.84% |
| Mar 31, 2022 | -19.52% |
| Dec 31, 2021 | -42.37% |
| Sep 30, 2021 | -33.96% |
| Jun 30, 2021 | 55.34% |
| Mar 31, 2021 | 98.23% |